Oracle Alpha Inc. 89bio, Inc. Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
A detailed history of Oracle Alpha Inc. transactions in 89bio, Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 12,414 shares of ETNB stock, worth $103,408. This represents 0.26% of its overall portfolio holdings.
Number of Shares
12,414
Previous 15,520
20.01%
Holding current value
$103,408
Previous $173 Million
16.65%
% of portfolio
0.26%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$126 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$118 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$66.6 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$61.5 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$58.4 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $387M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...